Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¸¼º°ñ¹ÝÅëÁõÈıº ȯÀÚÀÇ Ä¡·á¿¡¼­ º´ÇÕ¿ä¹ýÀÇ Ä¡·áÈ¿°ú: ÀüÇâÀû ¿¬±¸ Efficacy of Combination Therapy for Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Study

´ëÇѺñ´¢±â°úÇÐȸÁö 2006³â 47±Ç 5È£ p.536 ~ 540
¸ð±³ÀÍ, ÀÌ°æ¼·, ±è´ë°ï,
¼Ò¼Ó »ó¼¼Á¤º¸
¸ð±³ÀÍ ( Mo Kyo-Ik ) 
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

ÀÌ°æ¼· ( Lee Kyung-Seop ) 
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
±è´ë°ï ( Kim Dae-Gon ) 
µ¿±¹´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: The National Institute of Health(NIH) category III chronic nonbacterial prostatitis/chronic pelvic pain syndromes(CPPS) are commonly seen disorders; however, there has been no consensus on how to manage these patients. The purpose of this trial was to compare the efficacy of antibiotic monotherapy and antibiotic plus alpha-blocker combination therapy for the treatment of CPPS patients.

Materials and Methods: The study was comprised of 54 patients who were randomly placed into two groups: group I was treated with levofloxacin alone(28 patients), and group II was treated with levofloxacin and alfuzosin(26 patients). The levofloxacin, or the levofloxacin and alfuzosin were given to the respective groups for 8 weeks. The NIH Chronic Prostatitis Symptom Index(NIH-CPSI) was evaluated both before and after the treatment.

Results: Before the treatment, the mean CPSI of the group I patients was 23.1¡¾8.1, and after the treatment, it was 15.6¡¾5.6. For the group II, the mean CPSI before the treatment was 23.9¡¾8.3, and after the treatment, it was 11.0¡¾4.5. The difference between the pre- and post-treatment CPSI scores of group II was significantly larger than that of group I(p=0.001). The mean differences of the CPSI from the initial scores to the final scores in both groups were followed: ¡¾2.2 in group I and ¡¾4.3 in group II for the pain domain, ¡¾1.5 in group I and ¡¾2.8 in group II for the urinary domain, and ¡¾3.8 in group I and ¡¾5.7 in group II for the quality of life domain.

Conclusions: Combination therapy of levofloxacin with alfuzosin appeared more effective for treating patients with chronic prostatitis/chronic pelvic pain syndrome than just administering antibiotic alone. (Korean J Urol 2006;47:536-540)

Å°¿öµå

Pelvic pain;Chronic disease;Antibiotics;Adrenergic alpha blockers

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS